Nonorganic sleeping disorders, excluding more controls

KRA_PSY_SLEEP_NONORG_EXMORE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F51 Hospital discharge: ICD-9 — 3074 Hospital discharge: ICD-8 — 30640 Cause of death: ICD-10 — F51 Cause of death: ICD-9 — 3074 Cause of death: ICD-8 — 30640 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: KRA_PSY_ANYMENTAL

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F50-F59
Name in latin: Perturbationes somni non organicae

NAME	KRA_PSY_SLEEP_NONORG_EXMORE
CONTROL_EXCLUDE	KRA_PSY_ANYMENTAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F51
HD_ICD_9	3074
HD_ICD_8	30640
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F51
COD_ICD_9	3074
COD_ICD_8	30640
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Nonorganic sleeping disorders, excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	66627	34456	31779
Only index persons	60557	32275	28282
Unadjusted period prevalence (%)
Whole population	0.94	0.99	0.89
Only index persons	1.14	1.19	1.08
Median age at first event (years)
Whole population	40.02	41.74	38.15
Only index persons	40.66	42.32	38.76

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8711	5529	3182
Unadjusted period prevalence (%)	1.71	1.88	1.40
Median age at first event (years)	46.89	45.18	49.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7475: Matched controls
74759

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

599.0

323.0

1170

N06CA01

ATC

amitriptyline and psycholeptics; systemic

5.4

323.0

1092

2304

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

64.9

323.0

807

139

P03

ICPC

Feeling depressed

5.5

323.0

1104

2268

N05CD07

ATC

temazepam; oral

8.7

323.0

1380

1892

N06AX21

ATC

duloxetine; oral

8.1

323.0

1391

2056

N06AX26

ATC

vortioxetine; oral

10.6

323.0

813

854

F32.9

ICD-10 Finland

Depressive episode, unspecified

25.2

323.0

2129

1163

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

53.9

323.0

1148

251

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

978.5

323.0

460

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1395.6

323.0

520

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

331.4

323.0

577

N05AA02

ATC

levomepromazine; systemic

84.1

323.0

892

120

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

74.1

323.0

953

147

N05AH04

ATC

quetiapine; oral

31.7

323.0

3661

2198

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

121.0

323.0

1208

119

N05AN01

ATC

lithium; oral

121.9

323.0

382

P76

ICPC

Depressive disorder

9.6

323.0

799

924

N05AX08

ATC

risperidone; systemic

48.3

323.0

988

235

N06AX16

ATC

venlafaxine; oral

11.8

323.0

2033

2291

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

566.3

323.0

378

N05AX12

ATC

aripiprazole; systemic

241.7

323.0

741

N06AX12

ATC

bupropion; oral

16.3

323.0

1047

741

P29

ICPC

Psychological sympt/compl other

8.5

323.0

827

1079

F34.1

ICD-10 Finland

Dysthymia

41.1

323.0

546

143

P01

ICPC

Feeling anxious/nervous/tense

4.9

323.0

1387

3305

N05AH03

ATC

olanzapine; systemic

162.5

323.0

1292

N05CF01

ATC

zopiclone; oral

6.9

323.0

3760

9560

IGY02

NOMESCO Finland

Psychiatric monitoring contact

109.5

323.0

404

N06AA06

ATC

trimipramine; systemic

21.8

323.0

526

259

N03AX16

ATC

pregabalin; oral

3.7

323.0

2110

7250

N05BA04

ATC

oxazepam; oral

8.9

323.0

3284

6075

N06AB04

ATC

citalopram; systemic

7.2

323.0

2404

4594

N06AX03

ATC

mianserin; oral

19.7

323.0

815

461

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

70.5

323.0

1144

191

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

58.6

323.0

447

N06AB06

ATC

sertraline; oral

10.5

323.0

1546

1804

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

248.8

323.0

333

N06AX05

ATC

trazodone; oral

41.2

323.0

718

192

T36

ICD-10 Finland

Poisoning by systemic antibiotics

83.2

323.0

778

104

C07AA05

ATC

propranolol; systemic

4.0

323.0

2060

6558

N05BE01

ATC

buspirone; oral

34.5

323.0

436

134

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

323.0

547

N06AX22

ATC

agomelatine; oral

32.0

323.0

460

153

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

739.0

323.0

353

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

54.9

323.0

752

152

N06AB10

ATC

escitalopram; oral

6.7

323.0

2609

5566

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

15.5

323.0

1688

1381

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

30.6

323.0

1269

497

N03AE01

ATC

clonazepam; systemic

9.4

323.0

762

889

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

339.3

323.0

390

N03AG01

ATC

valproic acid; systemic, rectal

14.5

323.0

873

677

N05AF03

ATC

chlorprothixene; systemic

160.2

323.0

508

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

285.4

323.0

480

F29

ICD-10 Finland

Unspecified nonorganic psychosis

510.0

323.0

698

N05BA12

ATC

alprazolam; oral

6.5

323.0

1136

2005

R53

ICD-10 Finland

Malaise and fatigue

3.5

323.0

1933

6854

N06AX11

ATC

mirtazapine; oral

13.7

323.0

4933

9256

N05BA01

ATC

diazepam; systemic, rectal

7.0

323.0

1541

2666

N05CF02

ATC

zolpidem; oral

5.9

323.0

2425

5638

P06

ICPC

Sleep disturbance

6.0

323.0

1452

2867

N06AA12

ATC

doxepin; systemic

13.4

323.0

753

619

N03AX09

ATC

lamotrigine; oral

23.8

323.0

802

376

F41.1

ICD-10 Finland

Generalized anxiety disorder

16.5

323.0

860

583

N05AB03

ATC

perphenazine; systemic, rectal

49.9

323.0

469

100

F51.0

ICD-10 Finland

Nonorganic insomnia

60.2

323.0

5777

3998

N06AB03

ATC

fluoxetine; oral

8.4

323.0

1504

2185

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

15.0

323.0

1580

1310

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

19.3

323.0

551

306

SPAT1240

SPAT

Therapeutic discussion

4.8

323.0

1287

3079

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

+∞

323.0

589

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

10.7

323.0

1388

1562

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

123.4

323.0

863

F32.1

ICD-10 Finland

Moderate depressive episode

8.6

319.6

736

938

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

66.1

318.9

371

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

212.9

315.9

326

N05BA06

ATC

lorazepam; systemic, sublingual

14.4

312.9

549

410

F31.8

ICD-10 Finland

Other bipolar affective disorders

188.7

312.3

325

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

+∞

310.6

296

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

325.1

306.3

309

IGY99

NOMESCO Finland

Other psychiatric treatment contact

146.7

304.4

323

F61.0

ICD-10 Finland

Mixed personality disorders

174.1

302.8

317

P99

ICPC

Psychological disorders other

24.9

298.6

429

182

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

+∞

295.8

282

N06AB05

ATC

paroxetine; oral

8.1

295.5

708

958

N07BB01

ATC

disulfiram; oral

14.9

293.3

506

362

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

37.9

293.1

378

105

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

240.3

292.8

300

F99

ICD-10 Finland

Mental disorder, not otherwise specified

96.1

290.9

322

F51

ICD-10 Finland

Nonorganic sleep disorders

7.6

283.4

708

1020

F60.9

ICD-10 Finland

Personality disorder, unspecified

363.1

281.0

282

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

33.6

277.6

368

115

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

68.1

276.3

320

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

119.3

275.5

298

P74

ICPC

Anxiety disorder/anxiety state

10.3

269.2

555

578

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

1353.4

269.1

261

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

395.7

269.0

269

F10.20

ICD-10 Finland

Alcohol dependence currently independent

147.0

266.7

283

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

17.1

264.1

431

267

N06AA09

ATC

amitriptyline; systemic

5.1

263.4

916

2009

N03AX12

ATC

gabapentin; oral

3.6

260.3

1369

4421

F20.9

ICD-10 Finland

Schizophrenia, unspecified

652.7

257.1

253

F32

ICD-10 Finland

Depressive episode

7.6

251.9

624

883

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

326.2

247.7

250

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

363.3

247.1

248

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

42.8

242.1

304

F90.0

ICD-10 Finland

Disturbance of activity and attention

16.4

241.4

400

257

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

9.5

240.9

517

577

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2288.9

240.7

232

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

240.3

2969

16249

F41.09

ICD-10 Finland

UNS Panic Syndrome

16.2

234.0

389

252

N05AH02

ATC

clozapine; systemic

775.1

230.5

226

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

337.3

229.3

231

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

175.5

227.4

238

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

258.9

221.3

226

R51.80

ICD-10 Finland

Headache

3.0

221.0

1473

5596

N06AG02

ATC

moclobemide; oral

9.6

220.5

472

523

F39

ICD-10 Finland

Unspecified mood [affective] disorder

42.5

217.9

274

F43.1

ICD-10 Finland

Post-traumatic stress disorder

18.1

215.7

344

199

F10.09

ICD-10 Finland

Alcohol intoxication UNS

206.9

213.6

221

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.3

212.3

870

2233

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

248.2

212.0

217

Z71.8

ICD-10 Finland

Other specified counselling

2.5

211.0

2114

10222

A02BC02

ATC

pantoprazole; systemic

2.1

210.5

4513

31114

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

276.1

210.3

214

G47.3

ICD-10 Finland

Sleep apnoea

2.7

209.8

1671

7088

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

1962.4

208.1

201

G47.9

ICD-10 Finland

Sleep disorder, unspecified

10.1

204.9

424

441

N02AX02

ATC

tramadol; systemic, rectal

2.2

202.9

2940

16976

P72

ICPC

Schizophrenia

265.1

202.0

206

N05AD01

ATC

haloperidol; systemic

18.9

200.7

315

174

M79.6

ICD-10 Finland

Pain in limb

2.2

198.5

2678

14921

P15

ICPC

Chronic alcohol abuse

18.1

196.1

312

179

N06BA04

ATC

methylphenidate; oral

17.7

193.7

311

183

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

+∞

191.4

183

AA1AD

NOMESCO Finland

CT of head and brain

2.7

187.7

1535

6557

F40.1

ICD-10 Finland

Social phobias

19.0

187.4

293

160

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

+∞

187.2

179

F41.8

ICD-10 Finland

Other specified anxiety disorders

9.8

186.7

394

424

F10.25

ICD-10 Finland

Alcohol dependence continuous use

114.1

184.1

200

N04AA02

ATC

biperiden; systemic

49.4

177.0

216

F41.00

ICD-10 Finland

Moderate panic disorder

53.2

176.1

212

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

878.7

175.8

172

N05BA02

ATC

chlordiazepoxide; systemic

19.6

170.1

263

139

G44.2

ICD-10 Finland

Tension-type headache

2.9

168.4

1200

4678

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

38.3

168.3

216

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.0

167.8

583

1254

SPAT1307

SPAT

Psychosocial counselling and guidance

4.1

166.4

706

1853

F10.24

ICD-10 Finland

Alcohol depence active use

162.8

166.2

175

M54.5

ICD-10 Finland

Low back pain

2.1

165.3

2515

14492

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

1694.0

165.1

160

N04BC05

ATC

pramipexole; oral

4.3

162.3

644

1586

R42

ICD-10 Finland

Dizziness and giddiness

2.5

162.1

1486

6708

L03

ICPC

Low back symptom/complaint

2.3

160.3

1868

9520

N06AB08

ATC

fluvoxamine; oral

11.7

160.1

306

271

N05AA01

ATC

chlorpromazine; systemic, rectal

157.1

160.1

169

A06AC01

ATC

ispaghula (psylla seeds); oral

2.4

157.7

1658

8026

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

157.5

1916

9951

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

25.9

153.5

217

A06AD11

ATC

lactulose; oral

3.2

152.6

900

3075

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

25.1

152.0

217

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

753.2

150.7

148

F32.8

ICD-10 Finland

Other depressive episodes

25.1

150.6

215

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

23.0

149.4

219

R06.0

ICD-10 Finland

Dyspnoea

2.3

148.8

1669

8306

IBA03

NOMESCO Finland

Psychotherapy evaluation

308.5

148.1

150

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

737.6

147.6

145

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

+∞

147.3

141

F22.0

ICD-10 Finland

Delusional disorder

220.1

146.5

151

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

1470.6

146.3

142

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

146.2

1745

8931

F31

ICD-10 Finland

Bipolar affective disorder

87.2

144.8

162

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.6

144.1

702

2067

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

+∞

143.2

137

A04

ICPC

Weakness/tiredness general

2.8

140.4

1033

4073

N02BE01

ATC

paracetamol; systemic, rectal

2.1

139.5

6083

50688

AA400

NOMESCO Finland

Electroconvulsive therapy

+∞

137.9

132

C07AB07

ATC

bisoprolol; oral

1.9

135.5

2612

16217

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.9

134.2

467

1001

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.5

134.0

686

2098

R11

ICD-10 Finland

Nausea and vomiting

3.4

132.3

690

2140

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

659.7

132.0

130

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

7.6

131.6

321

437

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

7.4

129.9

322

449

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

129.4

3269

22231

F33

ICD-10 Finland

Recurrent depressive disorder

12.2

128.3

240

203

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

431.6

128.3

128

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

127.8

1801

9833

A01

ICPC

Pain general/multiple sites

3.7

127.4

611

1770

L17

ICPC

Foot/toe symptom/complaint

2.1

125.6

1728

9330

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

623.4

124.7

123

D11

ICPC

Diarrhoea

2.6

123.6

995

4116

SPAT1234

SPAT

Support of social functional capacity

6.0

123.5

358

619

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.4

123.1

1243

5811

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

254.3

122.3

125

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

+∞

122.2

117

IGV01

NOMESCO Finland

Psychiatric network contact

410.8

122.1

122

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.7

120.3

923

3710

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

1187.3

120.2

117

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

119.6

1363

6744

N05AE04

ATC

ziprasidone; systemic

400.5

118.9

119

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.3

118.5

660

2145

S06.0

ICD-10 Finland

Concussion

2.9

117.4

811

3054

P16

ICPC

Acute alcohol abuse

18.0

117.1

186

106

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

116.6

1725

9551

N05AL01

ATC

sulpiride; systemic

23.8

116.2

168

R03AC02

ATC

salbutamol; inhalant

1.8

115.8

3797

27708

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

93.0

115.4

128

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

114.8

1204

5717

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

114.7

5276

42721

D01

ICPC

Abdominal pain/cramps general

2.6

114.2

915

3763

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

+∞

113.8

109

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

+∞

113.8

109

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

+∞

113.8

109

P18

ICPC

Medication abuse

172.7

113.6

119

N05AB01

ATC

dixyrazine; systemic

29.3

113.6

155

A02BC01

ATC

omeprazole; systemic

2.0

113.0

1768

9993

IER01

NOMESCO Finland

Psychoeducation, group

1115.1

112.9

110

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

112.6

2562

16589

IEY01

NOMESCO Finland

Psychoeducation, individual

112.7

112.3

122

A02BC05

ATC

esomeprazole; systemic

1.8

112.0

2678

17618

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

1104.8

111.8

109

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

111.7

107

N05AC02

ATC

thioridazine; oral

12.1

111.2

208

176

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

111.0

2679

17667

188

Kela drug reimbursment

Psychosis requiring demanding treatment

+∞

110.7

106

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

110.0

1813

10440

WX110

NOMESCO Finland

Local anesthesy

1.8

109.5

5077

40844

M03BC01

ATC

orphenadrine (citrate); systemic

2.0

107.7

1783

10269

L01

ICPC

Neck symptom/complaint

2.4

107.6

1035

4690

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

106.5

102

N05CD02

ATC

nitrazepam; oral

15.2

106.4

180

121

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.2

106.2

619

2071

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

106.1

2195

13695

N05AD03

ATC

melperone; systemic

47.2

106.0

130

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

1043.0

105.6

103

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

105.4

101

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

272.2

105.1

107

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

105.1

1474

7941

SPAT1254

SPAT

Administration of medicine

2.4

104.2

1011

4597

M03BX02

ATC

tizanidine; oral

1.7

104.1

4398

34131

M25.5

ICD-10 Finland

Pain in joint

1.9

103.6

2029

12397

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

103.4

1213

6042

R52.2

ICD-10 Finland

Other chronic pain

5.8

103.3

307

547

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

103.2

1012

4625

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

103.0

3907

29347

F21

ICD-10 Finland

Schizotypal disorder

514.9

102.8

102

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

+∞

102.3

F41.3

ICD-10 Finland

Other mixed anxiety disorders

12.8

102.0

186

149

A28

ICPC

Limited function/disability NOS

2.8

101.4

726

2781

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

101.2

1178

5839

N06AA04

ATC

clomipramine; systemic

12.7

100.7

184

148

N03AX11

ATC

topiramate; oral

5.9

100.6

293

509

SPAT1243

SPAT

Psychiatric/psychological examination

5.7

100.4

302

546

P98

ICPC

Psychosis NOS/other

991.6

100.3

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

+∞

100.2

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

100.2

R52.9

ICD-10 Finland

Pain, unspecified

2.9

100.2

652

2352

N05AF01

ATC

flupentixol; systemic

17.8

100.0

159

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

258.8

100.0

102

A02BC03

ATC

lansoprazole; oral

1.9

99.3

1795

10632

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

+∞

99.2

R4110

NOMESCO Finland

Physiotherapy

1.9

98.8

1715

10005

R02

ICPC

Shortness of breath/dyspnoea

2.6

98.6

817

3410

XA800

NOMESCO Finland

Neuropsychological investigation

4.8

98.5

349

759

N05AF05

ATC

zuclopenthixol; systemic

253.5

97.9

100

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.5

97.4

840

3581

F51.1

ICD-10 Finland

Nonorganic hypersomnia

91.4

97.2

108

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

21.9

97.2

144

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

+∞

97.1

F43.29

ICD-10 Finland

Adaptation disorder UNS

9.3

96.5

207

228

K59.09

ICD-10 Finland

Constipation, unspecified

3.9

96.2

423

1132

J01DB01

ATC

cefalexin; oral

1.8

95.7

5895

50446

F50.9

ICD-10 Finland

Eating disorder, unspecified

44.3

95.1

118

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

95.0

1192

6096

S18

ICPC

Laceration/cut

1.7

94.7

2561

17272

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

94.0

1282

6786

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

93.6

3483

25731

F60.8

ICD-10 Finland

Other specific personality disorders

143.3

93.2

F60.5

ICD-10 Finland

Anankastic personality disorder

26.1

93.2

131

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

6.9

93.0

241

358

L28

ICPC

Limited function/disability (L)

2.4

92.8

849

3733

F33.8

ICD-10 Finland

Other recurrent depressive disorders

42.0

92.5

116

M79.1

ICD-10 Finland

Myalgia

2.3

92.5

965

4529

R74

ICPC

Upper respiratory infection acute

1.7

91.9

2347

15521

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

+∞

91.8

F43.00

ICD-10 Finland

Acute stress reaction mild

6.5

91.8

248

390

Z72.2

ICD-10 Finland

Drug use

93.1

91.2

101

G43.9

ICD-10 Finland

Migraine, unspecified

3.0

91.1

573

2016

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

90.8

1310

7086

N01

ICPC

Headache

2.3

90.8

954

4491

EBA00

NOMESCO Finland

Extraction of tooth

1.7

90.4

2327

15406

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

453.1

90.4

F93.89

ICD-10 Finland

Other childhood emotional disorders

453.1

90.4

R05

ICPC

Cough

1.9

90.2

1573

9148

K59.0

ICD-10 Finland

Constipation

3.8

90.1

409

1124

M79.7

ICD-10 Finland

Fibromyalgia

5.2

90.0

293

581

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

889.0

89.9

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

137.4

89.2

SPAT1260

SPAT

Consultation of another employee

2.1

89.1

1206

6353

N03AF01

ATC

carbamazepine; oral, rectal

4.2

88.7

362

905

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

442.9

88.3

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

8.5

88.2

199

239

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

868.5

87.8

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

87.7

3506

26234

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

87.7

887

4092

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

+∞

87.7

F32.0

ICD-10 Finland

Mild depressive episode

5.8

87.6

259

458

N17

ICPC

Vertigo/dizziness

2.6

86.7

719

2991

P01AB01

ATC

metronidazole; oral, rectal

1.7

86.4

2630

18233

IGY02

SPAT

57.4

86.2

102

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.4

86.0

441

1338

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

295.3

85.8

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

222.5

85.6

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

+∞

84.5

A02BA02

ATC

ranitidine; systemic

2.1

83.4

1143

6038

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

83.0

1695

10366

R41.0

ICD-10 Finland

Disorientation, unspecified

7.7

82.5

199

266

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

81.8

2853

20451

L02

ICPC

Back symptom/complaint

2.5

81.8

707

3005

R21

ICPC

Throat symptom/complaint

1.8

81.6

1712

10558

P73

ICPC

Affective psychosis

212.3

81.4

T74.1

ICD-10 Finland

Physical abuse

7.0

81.1

207

301

R00.2

ICD-10 Finland

Palpitations

2.8

80.8

581

2221

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.2

80.6

901

4349

B18.2

ICD-10 Finland

Chronic viral hepatitis C

18.3

80.2

126

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027008) Opiates [Presence] in Urine

1173

3302

3.95

307.65

2.7

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7218

52269

3.22

307.65

5.0

3.7

14.4

14.6

pmol/l

6.82

6776

48207

(3015377) Calcium [Moles/volume] in Serum or Plasma

3605

17564

2.80

307.65

2.8

3.4

2.3

2.4

mmol/l

0.52

3231

15625

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4353

23219

2.75

307.65

6.4

5.7

1.2

mmol/l

0.02

4031

21172

(3009466) Valproate [Moles/volume] in Serum or Plasma

454

196

24.38

307.65

6.2

2.6

383.7

341.9

umol/l

3.31

404

172

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2434

7077

4.39

307.65

2.3

1.4

1.5

1.3

62.35

2212

6414

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4832

29758

2.40

307.65

5.8

10.2

11.2

umol/l

8.45

4578

28237

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6801

46890

3.05

307.65

7.9

6.9

75.2

75.4

u/l

0.13

6501

44286

(3018418) pH of Serum or Plasma

3091

15078

2.63

307.65

4.0

7.4

1.10

490

2971

(3028300) Cannabinoids [Presence] in Urine

1182

3304

3.98

307.65

2.7

1.2

—

(3016879) Cocaine [Presence] in Urine

1146

2905

4.39

307.65

2.7

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4080

23445

2.39

307.65

4.6

4.8

36.6

36.3

g/l

2.84

3762

21922

(3000764) Benzodiazepines [Presence] in Urine

1181

3254

4.04

307.65

2.7

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1967

7617

3.04

307.65

1.9

1.7

1180.3

1163.3

nmol/l

0.33

1574

5852

(3027944) Amphetamines [Presence] in Urine

1147

3302

3.85

307.65

2.7

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3843

20098

2.63

307.65

3.7

2.9

29.4

32.8

u/l

3.40

3671

19202

(4198724)

236

36.72

307.65

3.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

858

374

25.34

307.65

3.0

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

298

32.11

307.65

1.7

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3021

15350

2.48

307.65

2.7

1.9

201.7

194.2

u/l

0.18

2847

14467

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4734

26054

2.79

307.65

7.0

6.3

1.2

mmol/l

0.70

4079

22081

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4242

24956

2.36

307.65

2.5

2.2

74.1

75.9

nmol/l

4.06

3929

23058

(1001926) Buprenorphine [Presence] in Urine by Screen method

1042

2194

5.26

307.65

2.8

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2592

10773

3.00

307.65

1.6

1.4

20.5

nmol/l

0.08

2369

9321

(3011288) Drugs identified in Urine by Screen method

985

1587

6.87

307.65

3.8

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4112

20631

2.88

307.65

2.2

1.8

98.8

97.6

pmol/l

0.78

2169

10929

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7869

62593

3.66

303.25

6.3

4.2

2.2

2.1

mu/l

0.05

7483

58419

(3013650) Neutrophils [#/volume] in Blood by Automated count

5458

37024

2.27

284.49

9.8

7.9

4.1

4.0

e9/l

4.58

4772

32557

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3227

17773

2.30

279.74

3.1

2.3

55.7

58.2

u/l

1.26

3014

16552

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4850

31572

2.21

277.07

3.5

2.7

89.1

100.9

ug/l

5.89

4553

29881

(3006315) Basophils [#/volume] in Blood

4869

32010

2.18

267.78

6.5

5.6

0.0

e9/l

0.01

4244

28124

(3001604) Monocytes [#/volume] in Blood

4850

31893

2.17

265.82

6.5

5.6

0.6

e9/l

0.82

4220

28057

(3013115) Eosinophils [#/volume] in Blood

4996

33236

2.18

265.78

6.9

5.6

0.2

e9/l

0.02

4411

29669

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2681

13927

2.34

263.91

2.5

2.1

2.7

2.8

mg/l

1.68

2299

12075

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1358

5133

2.95

257.33

2.1

2.2

371.2

373.3

nmol/l

0.15

1242

4756

(3013826) Glucose [Moles/volume] in Serum or Plasma

5155

35042

2.15

255.06

5.9

4.1

6.5

mmol/l

0.89

4852

31912

(3013707) Erythrocyte sedimentation rate by Westergren method

6470

48216

2.33

252.80

4.3

3.7

10.3

mm/h

0.06

6115

45189

(3019198) Lymphocytes [#/volume] in Blood

4948

33334

2.12

247.71

6.5

5.5

2.0

1.9

e9/l

2.68

4394

29885

(3019550) Sodium [Moles/volume] in Serum or Plasma

8099

67636

3.81

245.41

19.6

11.4

139.4

139.7

mmol/l

18.15

7969

65790

(44816559) Phosphatidylethanol [Mass/volume] in Blood

474

875

5.67

244.81

1.5

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

8101

67912

3.76

238.56

19.7

11.5

3.9

mmol/l

4.77

7953

65905

(42870588) Differential panel, method unspecified - Blood

3469

20652

2.13

238.51

6.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6331

47613

2.21

228.40

4.2

2.5

44.5

39.6

u/l

4.42

6036

45304

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1868

8796

2.43

225.19

2.6

3.0

2.4

mmol/l

8.44

1603

7712

(3044889) 12 lead EKG panel

5827

42694

2.10

221.40

3.9

3.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5830

42806

2.09

219.10

5.5

3.7

1876.8

1339.3

e6/l

0.19

512

(3022096) Basophils/100 leukocytes in Blood

4394

29170

2.02

218.66

6.6

5.8

0.7

1.09

4125

27387

(3019069) Monocytes/100 leukocytes in Blood

4527

30392

2.02

218.01

6.9

5.9

8.3

8.4

1.02

4271

28701

(3006504) Eosinophils/100 leukocytes in Blood

4505

30215

2.02

217.28

6.6

5.7

2.7

2.9

5.14

4229

28329

(3022948) Iron [Moles/volume] in Serum or Plasma

1805

8539

2.40

214.22

2.5

2.4

14.3

14.0

umol/l

1.15

1690

8029

(3018095) Leukocytes [#/volume] in Urine

3452

21189

2.04

212.23

4.3

3.2

84.5

88.0

e6/l

0.06

2435

14342

(3002030) Lymphocytes/100 leukocytes in Blood

4626

31806

1.97

202.33

6.7

5.7

29.3

29.2

0.39

4356

29911

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1669

7819

2.40

201.22

2.5

2.4

g/l

2.51

1545

7348

(3018010) Neutrophils/100 leukocytes in Blood

4566

31325

1.96

200.20

6.5

5.5

56.2

56.4

0.60

4305

29571

(3002582) Erythrocytes [#/volume] in Urine

2931

17260

2.05

199.24

3.7

2.9

70.6

82.4

e6/l

0.17

2263

13047

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

189

+∞

197.63

20.8

0.0

1351.0

—

nmol/l

—

180

(40758558) Short blood count panel - Blood

2669

15265

2.08

195.82

7.0

6.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

181

+∞

189.23

15.7

0.0

775.3

—

nmol/l

—

175

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1689

8160

2.33

188.60

3.2

3.5

0.8

mmol/l

1.71

1539

7660

(3009508) Creatinine [Moles/volume] in Urine

2841

16815

2.02

188.23

3.3

3.1

7.8

8.0

mmol/l

1.18

2445

14458

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7651

64058

2.60

188.02

4.9

3.6

5.8

5.7

mmol/l

10.71

7166

59650

(3030467) Casts [#/volume] in Urine by Automated count

2696

15676

2.04

187.57

3.5

2.8

0.3

0.4

e6/l

0.83

2032

11568

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3230

20074

1.97

185.43

4.6

2.9

57.6

45.8

ng/l

0.19

1917

11276

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2051

10819

2.17

184.39

1.7

1.6

37174109.7

33438125.8

pmol/l

0.10

1762

9262

(3020191) Ethanol [Moles/volume] in Serum or Plasma

213

222

9.81

183.06

1.9

1.1

1.4

1.0

promille

2.29

157

178

(3037467) Urinalysis macro (dipstick) panel - Urine

5968

45784

1.96

177.58

5.1

3.7

—

(36304419) Bacteria [Presence] in Urine

2649

15575

2.01

176.66

3.4

2.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1515

7188

2.34

175.27

2.6

2.5

23.9

23.7

0.13

1329

6247

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1188

5068

2.56

173.58

2.8

2.4

31.6

39.1

u/l

3.65

1011

4401

(3019150) Specific gravity of Urine by Refractometry

2348

13320

2.04

172.38

4.1

3.3

1.0

kg/l

1.75

286

2087

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

152

103

15.00

171.65

2.5

1.2

126.2

99.4

umol/l

0.35

(3033658) Prothrombin time (PT) actual/Normal

2555

14979

2.00

170.74

4.3

3.6

94.3

92.6

2.71

2476

14617

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2693

16185

1.96

166.75

1.4

1.3

1.6

1.7

u/ml

0.12

659

4697

(3007164) IgA [Mass/volume] in Serum or Plasma

2417

13995

2.01

166.64

1.5

1.4

2.2

g/l

0.43

1385

9245

(3026782) Osmolality of Urine

1986

10741

2.10

164.94

3.0

2.5

521.9

556.7

mosm/kgh2o

8.68

1660

9145

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1878

10100

2.10

157.42

4.0

3.3

202.4

570.7

ng/l

2.55

1226

7028

(3000850) Epithelial cells [#/volume] in Urine

2090

11801

2.01

152.69

2.8

2.4

7.1

6.1

e6/l

1.92

1813

10281

(3014111) Lactate [Moles/volume] in Serum or Plasma

984

4090

2.58

150.63

6.8

7.4

1.4

1.3

mmol/l

2.29

928

3962

(3023183) Ammonium ion [Moles/volume] in Plasma

342

724

4.88

150.63

2.3

3.0

31.2

34.2

umol/l

1.34

295

637

(3021589) Normoblasts [#/volume] in Blood

4123

29037

1.80

150.25

10.2

8.4

0.0

e9/l

0.88

3342

24003

(3023368) Bacteria identified in Blood by Culture

2318

13681

1.95

148.35

4.9

3.9

—

(3026008) Bacteria identified in Urine by Culture

2704

16802

1.88

147.86

3.5

2.5

—

(3012544) pH of Venous blood

1031

4425

2.51

147.39

4.7

3.9

7.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1002

4250

2.53

146.86

4.7

4.0

5.9

5.8

kpa

4.03

966

4134

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8019

70468

2.74

145.94

17.9

10.6

19.6

22.0

mg/l

10.09

6519

53819

(3002032) Base excess in Venous blood by calculation

994

4230

2.52

144.57

4.8

4.0

1.7

1.8

mmol/l

0.24

807

3419

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7061

59214

2.02

139.37

5.9

4.6

38.3

38.5

mmol/mol

1.06

6649

55842

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2331

14039

1.90

138.83

2.0

1.7

0.9

1.1

mg/l

4.57

1673

10538

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1155

5386

2.32

136.62

2.0

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2367

14394

1.88

136.43

3.8

3.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1715

9398

2.03

134.12

3.0

2.5

1.2

1.1

e6/l

0.48

953

5299

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1301

6431

2.20

133.49

6.0

6.1

1.1

1.0

mmol/l

0.52

1199

6056

(3024354) Oxygen [Partial pressure] in Venous blood

844

3447

2.60

133.27

4.1

3.4

4.8

4.7

kpa

0.99

810

3341

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1151

5435

2.29

131.91

2.0

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1629

8824

2.04

131.26

3.2

2.6

4.5

2.8

e6/l

4.15

870

4747

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7408

63609

2.10

130.87

15.2

9.8

89.5

87.4

ml/min/173m2

12.50

6127

52013

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1306

6535

2.17

129.68

2.4

2.8

6.6

7.3

umol/l

0.75

1070

5717

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1542

8222

2.06

129.58

2.1

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

4437

32782

1.72

129.46

4.0

3.1

0.0

estimate

1.34

792

6201

(3032080) INR in Blood by Coagulation assay

3167

21304

1.76

129.39

8.3

7.4

1.1

1.2

inr

4.63

1006

6522

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

28.01

127.49

1.9

2.7

13.7

17.9

umol/l

0.92

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8264

74592

3.11

126.82

12.2

8.4

27.2

26.4

u/l

2.53

8090

72311

(3009261) Glucose [Presence] in Urine by Test strip

4448

33240

1.69

121.33

4.1

3.1

0.0

estimate

0.78

812

6221

(3021601) Nitrite [Presence] in Urine by Test strip

4412

32972

1.69

119.71

5.4

4.2

0.0

estimate

0.08

834

6416

(3014576) Chloride [Moles/volume] in Serum or Plasma

1193

6031

2.13

114.37

7.1

7.0

104.1

104.7

mmol/l

4.25

1157

5907

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2118

13034

1.83

114.26

2.7

2.0

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

143

166

8.74

113.11

3.4

2.3

—

24.2

—

(3048689) Calprotectin [Mass/mass] in Stool

1606

9086

1.94

112.45

2.2

2.6

90.1

127.9

ug/g

6.41

1255

7316

(3002385) Erythrocyte distribution width [Ratio]

7015

60259

1.84

107.32

21.4

12.6

13.6

13.5

1.77

6919

59003

(3000991) Gas panel - Venous blood

877

4012

2.32

107.15

8.9

8.7

—

(40768797) Stomach Pathology biopsy report

1415

7793

1.97

106.68

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1918

11690

1.82

105.62

2.5

1.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2073

12994

1.78

103.62

3.2

2.9

1121.3

1184.6

ng/l

0.28

1671

10987

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1446

8193

1.92

99.62

2.1

2.3

29.3

29.7

1.70

1401

7951

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2384

15691

1.72

99.61

1.7

1.6

1.5

1.3

mmol/l

9.96

2110

13469

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

582

2287

2.66

98.51

5.5

4.4

24.2

mmol/l

0.04

517

2076

(3027801) Oxygen [Partial pressure] in Arterial blood

1042

5302

2.10

97.22

7.6

7.2

11.9

13.3

kpa

14.91

989

5053

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1042

5303

2.10

97.17

7.6

7.3

5.1

5.0

kpa

1.27

992

5056

(3003396) Base excess in Arterial blood by calculation

1039

5302

2.09

96.14

7.6

7.3

1.2

0.8

mmol/l

1.85

841

4056

(40761511) CBC panel - Blood by Automated count

8173

74913

2.48

92.68

16.0

9.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

726

3256

2.34

92.37

1.7

1.6

385.1

275.9

mu/l

4.84

636

2958

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

843

4081

2.18

89.10

3.2

3.6

4.5

4.6

pmol/l

1.93

733

3722

(1002224) Polysomnography panel

697

3125

2.34

88.63

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

400

1377

3.00

86.70

1.4

1.3

403.2

520.4

mg/l

8.60

386

1323

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

773

3653

2.22

86.66

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

364

1197

3.13

85.41

1.3

1.4

4.0

26.9

e6/l

4.11

274

935

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

363

1197

3.12

84.77

1.4

1.5

305.0

1605.4

e6/l

1.46

290

980

(3004119) Hemoglobin [Mass/volume] in Venous blood

628

2756

2.38

83.73

3.9

3.4

132.7

130.2

g/l

2.00

616

2697

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

663

2981

2.32

83.62

1.6

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

360

1197

3.09

82.87

1.3

3.7

mmol/l

0.11

338

1130

(3016502) Oxygen saturation in Arterial blood

918

4717

2.06

82.73

8.1

7.7

95.4

96.1

2.24

889

4526

(3000494) Fungus identified in Specimen by Culture

1229

6982

1.89

82.71

1.5

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1345

7920

1.83

80.56

2.2

1.9

—

(36660697) Celiac disease serology panel - Serum

1041

5656

1.95

79.98

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

384

1372

2.88

77.76

1.4

320.1

283.2

ug/g

1.01

213

780

(3007853) Bacteria identified in Skin by Aerobe culture

1201

6903

1.86

77.54

1.9

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

641

2948

2.27

76.46

1.6

3.2

3.4

mg/l

0.23

526

1891

(3037522) Nuclear Ab [Titer] in Serum

1500

9256

1.75

76.25

1.4

446.5

592.2

titre

2.55

240

1910

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

496

2040

2.52

76.07

3.9

2.9

0.7

0.6

1.25

482

1947

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

397

1465

2.79

75.67

2.2

2.3

629.8

424.9

ug/l

0.53

368

1363

(3017446) Testosterone [Moles/volume] in Serum or Plasma

895

4709

2.00

75.19

2.6

2.0

12.7

12.4

nmol/l

0.50

794

4265

(3002173) Hemoglobin [Mass/volume] in Arterial blood

849

4396

2.03

74.57

8.5

8.1

123.0

122.1

g/l

0.55

826

4226

(3023511) Choriogonadotropin [Units/volume] in Urine

497

2070

2.49

74.18

1.5

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

844

4369

2.03

74.17

7.7

7.8

8.2

9.1

mmol/l

3.16

806

4194

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

891

4705

2.00

74.04

2.4

2.3

0.2

g/l

3.37

817

4443

(3029937) Albumin [Presence] in Urine by Test strip

2440

17175

1.58

73.91

4.5

3.4

0.0

estimate

0.33

798

6213

(46235355) HIV 1 and 2 tests - Meaningful Use set

2636

18890

1.57

73.85

2.4

1.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

987

5409

1.93

73.57

2.4

2.7

1.8

1.7

0.89

843

4880

(3017143) Hepatitis C virus Ab [Presence] in Serum

1548

9739

1.72

73.09

1.9

1.6

—

(3042517) Benzodiazepines panel - Urine

113.90

72.96

2.4

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

595

2729

2.27

71.32

1.8

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1300

7835

1.77

71.30

2.5

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7596

68994

1.79

69.79

4.9

4.0

2.8

mmol/l

6.75

7108

64961

(3014765) Yersinia sp identified in Stool by Organism specific culture

434

1753

2.55

69.06

1.2

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1768

11679

1.64

68.86

1.4

1.3

26.8

29.8

iu/ml

0.26

466

3821

(42529406) Shigella sp [Presence] in Stool by Culture

434

1763

2.54

68.23

1.2

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

581

2688

2.24

68.14

1.1

37.3

1.5

u/ml

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

430

1742

2.54

67.99

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

598

2805

2.22

67.80

2.1

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

525

2375

2.29

64.91

1.9

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

323

1159

2.86

64.82

1.3

1.4

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

26.01

63.42

1.2

1.0

—

mmol/l

—

(3003181) Sodium [Moles/volume] in Urine

219

637

3.50

62.62

1.5

1.3

57.5

67.1

mmol/l

2.51

170

512

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

834

4553

1.92

62.39

2.3

21.0

22.4

au/ml

0.12

368

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

737

3866

1.99

61.97

3.1

2.1

4.9

7.6

ug/l

5.61

613

3433

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1043

6132

1.80

61.59

2.3

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1039

6104

1.80

61.50

21.5

21.1

1.2

1.3

inr

1.39

120

983

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7482

68253

1.68

60.21

4.4

3.7

4.6

4.7

mmol/l

15.95

7026

64687

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

286

1006

2.91

59.52

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

286

1007

2.90

59.42

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

774

4194

1.93

59.09

1.3

43.0

45.6

au/ml

0.08

194

(3008152) Bicarbonate [Moles/volume] in Arterial blood

581

2856

2.11

58.27

7.9

6.3

24.7

24.3

mmol/l

2.15

550

2624

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7438

67878

1.66

58.17

4.4

3.7

1.4

1.5

mmol/l

32.22

6967

64158

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1647

11091

1.60

58.07

1.3

1.2

7.9

11.5

u/ml

1.59

584

4798

(3013139) Helicobacter pylori Ag [Presence] in Stool

777

4246

1.91

57.78

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

468

2120

2.28

57.58

3.7

3.3

25.1

mmol/l

0.02

449

2056

(3019060) Gas panel - Arterial blood

583

2913

2.07

55.94

5.4

4.5

—

(3044640) Blood type and Crossmatch panel - Blood

2677

20222

1.47

54.63

2.4

2.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

735

4046

1.89

53.30

1.1

1.0

—

(3024928) Oxygen saturation in Venous blood

271

984

2.81

53.18

4.2

3.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2344

17337

1.48

52.91

1.9

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

312

1221

2.61

52.90

1.6

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

591

3035

2.02

52.53

4.3

3.6

5.2

5.1

kpa

1.29

551

2815

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

144

6.23

52.51

1.0

239.0

293.1

ng/l

1.27

100

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

568

2879

2.04

52.35

4.3

3.6

1.6

1.5

mmol/l

0.20

419

2049

(3005719) IgG [Mass/volume] in Serum or Plasma

821

4709

1.82

52.20

2.4

2.6

10.1

10.6

g/l

3.60

743

4333

(3009343) pH of Capillary blood

583

2989

2.02

52.05

4.3

3.6

7.4

0.20

373

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

676

3652

1.92

51.86

4.1

4.0

87.6

87.2

ng/l

0.03

585

3249

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

326

1318

2.53

51.68

2.4

1.8

191.4

195.6

pmol/l

0.26

306

1271

(3007461) Platelets [#/volume] in Blood

8474

81054

2.68

51.35

26.7

15.2

257.9

256.0

e9/l

2.06

8345

79145

(3052851) Hemolysis interference index of Serum or Plasma

365

1564

2.39

51.00

2.8

2.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3284

26023

1.42

50.80

4.2

3.1

—

(3035941) MCH [Entitic mass]

8477

81143

2.67

50.43

26.5

15.1

30.3

30.1

9.93

8411

80206

(3023410) Appearance of Cerebral spinal fluid

184

552

3.38

50.18

1.5

1.7

—

(3024731) MCV [Entitic volume]

8476

81151

2.65

49.99

26.6

15.1

90.6

90.2

14.68

8408

80213

(3026361) Erythrocytes [#/volume] in Blood

8477

81166

2.66

49.97

26.6

15.1

4.5

4.6

e12/l

12.59

8331

79113

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

904

5402

1.75

49.91

1.3

1.2

115.8

158.2

iu/ml

2.62

306

2200

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

145

6.05

49.84

1.0

32.2

37.5

ng/l

0.55

(3023520) Reticulocytes [#/volume] in Blood

705

3910

1.87

49.84

2.6

2.7

70.7

69.1

e9/l

0.54

493

2915

(3025941) Bacteria identified in Stool by Culture

706

3918

1.87

49.81

1.3

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

128

300

4.32

49.67

1.6

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

143

6.06

49.39

1.0

853.0

830.3

ng/l

0.14

(3000963) Hemoglobin [Mass/volume] in Blood

8477

81204

2.64

49.22

26.8

15.2

135.6

136.4

g/l

6.51

8409

80270

(3010813) Leukocytes [#/volume] in Blood

8476

81196

2.63

49.10

26.7

15.2

6.8

6.6

e9/l

11.67

8333

79098

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7168

65456

1.54

49.03

3.9

3.4

1.4

1.2

mmol/l

23.62

6667

61719

(3006653) Thiamine [Moles/volume] in Blood

105

215

4.93

48.11

1.4

146.1

134.3

nmol/l

1.16

105

215

(3009214) Lutropin [Units/volume] in Serum or Plasma

501

2505

2.06

47.86

1.4

1.3

8.7

9.5

u/l

0.72

385

2096

(3015171) Extractable nuclear Ab [Units/volume] in Serum

513

2593

2.04

47.57

1.3

1.2

0.4

1.2

u/ml

2.49

213

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

591

3149

1.94

47.13

8.1

7.7

24.8

24.6

mmol/l

0.67

583

3135

(3023323) Follitropin [Units/volume] in Serum or Plasma

780

4542

1.79

46.96

1.4

1.3

23.7

26.7

iu/l

1.74

639

3986

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

435

2079

2.15

46.78

2.1

1.6

42.7

41.2

nmol/l

0.62

430

2043

(3012516) Albumin [Mass/volume] in Urine

2060

15188

1.47

46.13

3.2

3.3

499.1

401.8

mg/l

0.36

1295

9716

(40760892) CBC W Ordered Manual Differential panel - Blood

2130

15818

1.46

45.90

4.5

3.9

—

(3013512) EKG study

2069

15288

1.46

45.74

4.3

3.3

—

(3008295) Osmolality of Serum or Plasma

145

404

3.63

44.32

1.5

1.4

278.3

280.4

mosm/kgh2o

0.46

111

325

(3020682) Albumin/Creatinine [Ratio] in Urine

2134

15946

1.45

44.23

3.9

4.0

8.3

9.0

mg/mmol

0.28

1347

10362

(3020630) Protein [Mass/volume] in Serum or Plasma

679

3882

1.81

43.35

1.9

2.6

66.5

66.9

g/l

0.55

618

3597

(40761535) Cells panel - Urine sediment

735

4303

1.77

43.33

3.7

3.1

—

(1616796) Gas panel - Central venous blood

263

1048

2.56

42.98

3.5

3.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

262

1049

2.54

42.39

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

642

3643

1.82

41.98

1.8

1.3

g/l

0.10

588

3372

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

478

2485

1.98

40.87

9.6

9.8

24.3

mmol/l

0.09

436

2343

(21494755) Public health laboratory ask at order entry panel

653

10797

0.57

40.35

1.3

—

(3020891) Body temperature

371

1777

2.14

39.64

5.7

4.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

297

1301

2.33

39.46

4.8

3.7

3.8

3.9

mmol/l

2.31

273

1215

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3835

32091

1.35

39.03

4.1

3.9

—

(3027315) Oxygen [Partial pressure] in Blood

262

1094

2.44

38.77

4.2

3.7

9.0

8.8

kpa

1.03

254

1080

(3005322) IgE [Units/volume] in Serum or Plasma

767

4686

1.70

38.68

1.3

175.0

202.5

u/ml

0.41

706

4339

(4010399)

674

3975

1.75

38.60

1.4

—

(3012501) Base excess in Blood by calculation

260

1085

2.44

38.53

4.1

3.7

2.2

2.4

mmol/l

0.46

174

695

(3013290) Carbon dioxide [Partial pressure] in Blood

260

1086

2.44

38.45

4.1

3.7

5.0

kpa

0.86

252

1072

(3010421) pH of Blood

290

1275

2.32

38.21

4.0

3.7

7.4

0.93

252

1072

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

480

2571

1.92

37.55

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

+∞

37.52

5.3

0.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

736

4507

1.69

36.73

2.7

2.2

6173.9

6229.1

u/l

0.01

262

2021

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

968

6363

1.59

36.37

8.0

5.4

—

(3016018) Differential panel - Cerebral spinal fluid

177

629

2.85

36.23

1.3

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

7375

68719

1.48

36.21

19.4

11.0

40.3

0.13

5710

55247

(3015235) Bicarbonate [Moles/volume] in Capillary blood

271

1185

2.33

36.17

3.4

3.2

24.3

24.5

mmol/l

0.20

240

1030

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

247

1042

2.41

35.75

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

546

3109

1.81

35.18

1.7

2.3

—

(3003338) MCHC [Mass/volume]

6960

64270

1.41

34.87

23.1

12.7

333.2

g/l

0.01

6912

63784

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

236

987

2.43

34.83

1.9

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

13.25

34.80

1.2

—

(40768804) Tissue Pathology biopsy report

3312

27430

1.33

34.80

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2001

15337

1.40

34.50

2.3

2.1

—

(3022145) Colonoscopy Study observation

1029

6967

1.54

33.80

1.3

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

682

4206

1.67

33.03

4.1

3.5

1.2

mmol/l

2.46

604

3726

(3047181) Lactate [Moles/volume] in Blood

327

1622

2.06

31.86

5.7

5.4

1.4

1.2

mmol/l

1.41

285

1423

(3026493) Urate [Moles/volume] in Serum or Plasma

2044

15951

1.37

31.03

2.5

2.4

3000.2

3799.6

umol/l

0.53

1777

14260

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

211

4.06

30.70

1.9

1.4

2324252.7

2462954.3

iu/ml

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

946

6417

1.53

30.64

1.6

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

403

2179

1.89

30.60

1.9

1.8

1.5

1.4

g/l

0.51

348

1873

(3020961) Endomysium IgA Ab [Titer] in Serum

602

3673

1.69

30.31

1.1

52.3

265.4

titre

4.37

108

(3019225) pH of Specimen

758

4905

1.60

30.20

4.4

3.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

835

5529

1.56

30.13

4.1

2.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

447

2514

1.82

29.95

1.6

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

467

2669

1.79

29.66

9.7

9.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6141

56057

1.32

29.60

3.9

3.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

362

1933

1.91

28.56

1.9

1.7

0.2

g/l

0.12

342

1841

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

732

4775

1.58

28.13

2.8

2.4

72.3

71.1

ml/min/173m2

0.34

291

1798

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

277

1358

2.07

27.87

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

468

2727

1.76

27.81

2.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

333

1747

1.94

27.70

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

368

2000

1.88

27.51

1.9

1.7

1.2

g/l

0.57

348

1907

(3030981) Hyaline casts [#/volume] in Urine by Automated count

491

2919

1.72

27.17

3.1

2.5

0.4

0.3

e6/l

0.68

470

2817

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

166

666

2.52

26.86

1.1

—

59.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

169

684

2.50

26.85

1.1

—

11.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

876

6013

1.51

26.66

3.5

4.6

223.9

240.2

u/l

4.28

818

5748

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

11.23

26.65

1.2

1.3

48.0

36.9

mg/l

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

658

4241

1.60

26.57

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

591

9087

0.62

26.24

1.6

—

(3022313) Gas panel - Capillary blood

388

2186

1.81

25.84

4.8

3.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

171

716

2.42

25.27

1.5

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

286

3.31

25.25

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

612

3960

1.59

24.26

2.7

2.8

174.7

174.5

ng/l

0.00

528

3566

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

263

1334

2.00

24.14

1.5

2.3

0.0

g/l

0.13

239

1244

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

280

1452

1.96

24.13

1.2

1.3

46.8

41.5

u/ml

0.16

153

(3048929) Epstein Barr virus Ab [Presence] in Serum

470

2857

1.68

23.94

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

181

800

2.29

23.68

1.2

1.3

0.6

2.0

nmol/l

0.49

175

779

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

337

1875

1.83

23.40

1.2

1.3

52.8

43.8

u/ml

0.14

139

(3028271) Lactate [Moles/volume] in Capillary blood

172

749

2.32

23.30

2.5

1.7

1.8

1.7

mmol/l

0.58

167

732

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

322

1769

1.85

23.29

2.2

1.9

2.2

2.0

ug/l

0.10

286

1572

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

309

1676

1.87

23.27

1.6

2.3

2.9

3.1

g/l

1.57

244

1327

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

181

807

2.27

23.20

1.3

0.2

0.3

nmol/l

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

322

1773

1.85

23.12

1.6

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

322

1773

1.85

23.12

1.6

2.3

3.7

3.8

g/l

0.48

234

1278

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

234

1156

2.05

23.12

1.4

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

322

1775

1.85

23.04

1.6

2.3

7.1

7.4

g/l

2.13

242

1355

(3025130) Human papilloma virus identified in Specimen

238

1190

2.03

22.76

1.7

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

303

1646

1.87

22.71

1.5

2.4

9.6

10.4

g/l

2.82

253

1408

(3049717) Cytology report of Urine Cyto stain

303

1647

1.87

22.67

2.3

2.6

—

(40767503) Oxygen content in Capillary blood by calculation

213

1024

2.11

22.64

3.0

2.2

17.0

16.7

0.37

109

516

(4034850)

340

1917

1.80

22.61

10.3

7.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

133

523

2.57

22.51

1.9

2.2

20.4

20.1

nmol/l

0.16

125

507

(3021901) Oxygen saturation in Capillary blood

184

843

2.21

22.11

2.9

2.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

280

1497

1.90

22.05

1.8

2.4

0.6

0.8

g/l

0.53

244

1318

(3036180) Methadone [Presence] in Urine

+∞

21.88

2.0

0.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

297

3.09

21.83

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

148

624

2.40

21.60

1.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

238

1217

1.98

21.39

4.4

4.0

8.7

8.6

kpa

0.15

224

1128

(3036489) Thrombin time

404

2431

1.69

21.38

2.1

2.2

20.8

21.3

1.43

349

2075

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

239

1225

1.98

21.34

1.5

2.3

0.0

g/l

0.50

217

1140

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

351

2034

1.76

21.28

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

337

1935

1.77

21.09

5.0

3.8

24.6

24.7

mmol/l

0.10

316

1798

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

274

1477

1.88

21.06

1.8

1.4

0.4

0.5

nmol/l

0.14

230

1198

(3007566) Smooth muscle Ab [Titer] in Serum

310

1742

1.81

20.86

1.3

64.5

138.6

titre

1.50

174

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

+∞

20.84

2.1

0.0

—

(3016038) Potassium [Moles/volume] in Urine

254

3.21

20.79

1.3

1.2

31.1

35.5

mmol/l

0.90

218

(3013005) Retinol [Moles/volume] in Serum or Plasma

255

3.20

20.66

1.7

1.9

2.0

1.9

umol/l

1.01

239

(3024980) IgG subclass 4 [Mass/volume] in Serum

215

1075

2.03

20.60

1.5

1.6

0.7

0.8

g/l

0.48

158

808

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

235

1215

1.96

20.48

1.5

2.3

0.0

g/l

0.00

217

1138

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

247

1301

1.92

20.38

1.5

1.3

20.1

23.7

u/l

1.05

203

1085

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

255

1358

1.90

20.35

1.5

2.2

39.2

38.1

g/l

2.55

222

1191

(3017509) Phencyclidine [Presence] in Urine

5.61

20.34

3.6

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

125

503

2.51

20.21

1.3

1.4

—

(4062490)

152

671

2.29

20.01

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

275

1509

1.85

20.00

1.5

1.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

293

2.99

19.81

1.5

73.2

72.1

0.30

286

(3034770) Mitochondria Ab [Titer] in Serum

305

1733

1.79

19.79

1.2

1.3

1041.4

999.5

titre

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

276

1522

1.84

19.77

2.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

338

1982

1.73

19.67

5.5

4.8

1.9

1.6

3.90

321

1852

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

323

2.87

19.45

1.1

0.4

6.4

nmol/l

2.66

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

156

708

2.23

19.24

1.2

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

421

2633

1.63

19.20

2.0

39.4

u/l

0.02

391

2405

(3027135) IgG subclass 1 [Mass/volume] in Serum

149

670

2.25

18.80

1.3

6.0

6.9

g/l

3.08

100

446

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

286

2.96

18.78

1.5

574.9

435.2

mu/l

0.63

279

(3007930) Methemoglobin/Hemoglobin.total in Blood

332

1964

1.72

18.73

5.7

4.9

0.9

1.05

315

1837

(1761868) Lipid panel - Serum or Plasma

2473

28875

0.80

18.71

2.7

2.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

158

3.69

18.53

1.6

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

269

1505

1.81

18.40

1.4

15.8

25.1

u/ml

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

148

670

2.23

18.38

1.3

0.4

g/l

1.04

446

(3028192) IgG subclass 2 [Mass/volume] in Serum

148

670

2.23

18.38

1.3

3.0

g/l

0.12

447

(3045716) Anion gap in Serum or Plasma

178

3.50

18.34

2.2

2.6

9.1

mmol/l

0.02

136

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

255

1409

1.83

18.17

1.5

1.4

105.3

111.1

u/ml

0.47

298

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

296

1711

1.76

18.14

1.2

1.3

1.7

5.7

u/ml

1.48

182

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

405

6251

0.63

17.95

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

359

2199

1.66

17.79

1.1

3.5

5.5

u/ml

0.83

349

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

357

2185

1.66

17.74

1.5

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

298

1737

1.74

17.74

1.2

1.3

5.3

10.2

u/ml

1.44

292

(3041096) Erythrocytes [Presence] in Urine by Automated

2285

19268

1.25

17.67

3.7

2.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

329

1973

1.69

17.67

1.2

—

(3008898) HLA-B27 [Presence]

446

2889

1.57

17.58

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

128

3.92

17.46

1.6

1.2

97.6

112.6

nmol/l

0.42

(3024891) Influenza virus A+B Ag [Presence] in Specimen

321

1923

1.69

17.31

1.2

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

329

1984

1.68

17.31

2.3

2.6

175.2

178.3

0.27

310

1890

(3006184) Hemoglobin [Mass/volume] in Capillary blood

220

1179

1.89

17.28

2.2

134.8

131.1

g/l

1.35

156

847

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

124

537

2.33

17.13

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

131

585

2.26

16.85

56.3

4.3

7.5

7.3

mmol/l

0.15

106

483

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

149

704

2.14

16.68

1.2

1.3

—

nmol/l

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

324

1966

1.67

16.66

1.7

138.5

351.8

titre

1.74

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

263

1507

1.77

16.64

1.2

1.3

260.4

250.4

u/ml

0.24

175

955

(3017181) Myelocytes/100 leukocytes in Blood

694

4979

1.43

16.59

4.3

4.1

0.9

0.19

196

1242

(3002179) Metamyelocytes/100 leukocytes in Blood

642

4552

1.44

16.36

3.8

3.9

0.6

0.5

0.10

147

913

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

274

1598

1.74

16.31

1.2

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

209

3.13

16.10

1.5

1.6

14.4

15.1

pmol/l

0.46

184

(3044242) Glucose [Moles/volume] in Arterial blood

199

3.18

16.07

1.9

1.8

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

324

2.67

15.99

1.5

1.4

24.9

28.2

umol/l

0.41

309

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

124

555

2.25

15.89

1.2

30.7

42.7

mg/l

5.79

107

458

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

120

532

2.27

15.74

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1877

15652

1.25

15.70

4.6

4.5

1.9

3.0

ug/l

2.18

1696

14285

(3026389) Candida sp identified in Specimen by Organism specific culture

180

934

1.95

15.62

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

107

453

2.38

15.60

1.2

1.7

1.9

mmol/l

2.69

424

(3025159) Blasts/100 leukocytes in Blood

636

4545

1.43

15.52

4.4

4.1

0.0

0.3

1.30

156

974

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

106

448

2.38

15.52

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

106

449

2.38

15.44

1.3

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

663

4780

1.42

15.40

4.3

4.1

0.1

0.2

0.24

183

1161

(4027681)

102

428

2.40

15.18

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1884

15799

1.25

14.88

1.8

1.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

120

546

2.21

14.81

1.1

214.6

250.3

mg/l

2.06

108

484

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

152

3.37

14.32

2.3

2.7

27.6

27.4

umol/l

0.03

109

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

173

915

1.91

14.23

1.7

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

204

1137

1.81

14.22

2.2

2.1

0.9

0.8

nmol/l

0.71

173

972

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

259

1547

1.69

14.19

3.2

3.8

0.3

u/ml

0.10

130

884

(3035947) Staphylolysin Ab [Units/volume] in Serum

267

2.71

13.86

1.2

1.1

3.4

4.2

iu/ml

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

246

2.78

13.73

1.5

1.9

29.2

28.7

umol/l

0.17

235

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

205

3491

0.58

13.58

1.8

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

105

3.82

13.56

1.0

93.1

77.3

ug/l

1.54

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

158

826

1.93

13.48

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

335

2162

1.57

13.47

2.2

2.5

94.9

92.8

0.98

310

2013

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

231

1364

1.71

13.23

1.2

1.3

18.1

3.5

u/ml

0.57

117

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

257

1571

1.66

12.93

2.0

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

283

2.59

12.91

1.4

1.6

4.3

2.7

nmol/l

0.42

229

(3051611) Lipemic interference index of Serum or Plasma

117

558

2.11

12.89

3.1

3.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

218

1281

1.72

12.72

1.4

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

246

2.70

12.62

1.3

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

165

2917

0.56

12.56

1.4

1.5

—

(3022621) pH of Urine by Test strip

565

4115

1.40

12.38

3.3

2.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

267

1667

1.62

12.37

3.9

4.1

1.5

1.4

mg/l

1.18

246

1556

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

192

1099

1.76

12.30

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

104

484

2.16

12.22

1.4

1.3

5.0

5.8

umol/l

1.14

457

(3051651) Icteric interference index of Serum or Plasma

333

2.42

12.21

3.3

3.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

195

1124

1.75

12.20

1.3

1.2

3.4

3.8

u/ml

0.27

503

(43055514) Macroprolactin [Presence] in Serum or Plasma

240

2.68

12.11

1.5

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

180

1019

1.78

11.99

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

445

2.19

11.83

3.6

4.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

115

567

2.04

11.65

1.2

73.5

63.8

u/l

0.48

389

(3000492) Spirometry study

906

7152

1.30

11.60

1.5

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

132

3.27

11.59

3.0

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

132

3.27

11.59

3.0

2.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

101

477

2.13

11.47

3.1

24.8

25.6

mu/l

0.08

453

(3011985) Renin [Units/volume] in Plasma

146

786

1.87

11.46

1.5

1.6

63.9

59.2

mu/l

0.11

130

715

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

+∞

11.46

1.5

0.0

16.8

—

nmol/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

231

3658

0.62

11.44

1.5

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

485

3491

1.41

11.38

1.4

1.3

229.7

223.4

miu/ml

0.13

196

1808

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

117

588

2.00

11.26

7.2

6.6

11.3

11.0

mg/l

0.28

106

555

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

213

1297

1.66

10.94

1.7

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

557

7402

0.74

10.87

1.4

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

154

859

1.81

10.82

2.0

1.7

1840.0

1542.9

titre

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

271

1756

1.56

10.78

1.7

2.0

3.3

4.3

iu/l

1.22

740

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

205

1241

1.67

10.78

1.1

7.7

9.4

au/ml

—

100

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

299

1988

1.52

10.59

3.0

2.8

3.6

g/l

0.18

281

1881

(3047007) Chlamydophila sp Ab [Presence] in Serum

190

1133

1.69

10.58

1.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

153

858

1.80

10.57

1.2

1.3

80.5

51.5

u/ml

—

(3045414) Leukocytes [Presence] in Urine

412

2921

1.43

10.54

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

178

2.82

10.49

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

258

1667

1.56

10.41

1.9

2.1

11.5

10.6

mg/l

0.80

235

1579

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

106

532

2.00

10.28

1.1

—

69.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

164

950

1.74

10.16

1.6

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

295

2.35

10.00

1.2

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

206

1274

1.63

10.00

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

145

2.98

9.96

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

195

1193

1.65

9.88

1.3

1.2

3.0

3.6

u/ml

0.27

421

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

335

2.25

9.83

1.3

1.4

8.5

6.0

u/l

0.61

289

(3019977) pH of Arterial blood

243

2.48

9.80

2.7

2.3

7.4

0.52

(40768443) Skin Pathology biopsy report

378

2676

1.43

9.77

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

131

3.06

9.75

1.0

1.1

—

(3039000) Anion gap in Blood

185

1122

1.66

9.70

7.8

6.5

11.4

11.1

mmol/l

0.47

169

1002

(3019420) Tryptase [Mass/volume] in Serum or Plasma

363

2.19

9.68

1.6

1.5

6.2

7.3

ug/l

0.57

324

(3018572) Chloride [Moles/volume] in Blood

185

1123

1.66

9.67

7.8

6.5

104.1

105.5

mmol/l

2.41

169

1003

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

198

2.64

9.63

2.9

2.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

199

2.62

9.54

2.4

2.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

160

2.82

9.50

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

213

1350

1.59

9.38

2.3

3.5

46.6

98.9

mg/l

0.67

171

1108

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

178

2.71

9.37

1.1

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.95

9.30

1.0

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

176

1067

1.66

9.27

1.2

—

250.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

207

1309

1.60

9.21

2.1

3.5

1.4

1.9

ratio

0.63

113

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1474

12592

1.21

9.20

4.1

3.9

21.6

21.9

0.30

584

5524

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

478

2.00

9.20

1.1

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

212

1350

1.58

9.16

2.3

3.5

33.8

59.5

mg/l

1.61

170

1117

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

192

2.61

9.13

1.4

1.2

—

(3011648) Oxygen content in Venous blood

426

2.05

9.08

2.5

3.5

10.7

11.3

0.76

426

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

216

2.51

9.08

1.3

1.2

103.8

108.4

0.62

192

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

460

2.01

9.07

1.4

10.8

11.8

umol/l

0.48

445

(3037121) Protein [Mass/volume] in Urine

279

1892

1.49

9.05

3.3

0.3

0.4

g/l

0.82

124

844

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

203

1285

1.59

9.00

4.7

5.7

1333.6

1845.1

iu/ml

0.13

171

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

329

2.20

8.98

1.2

21.4

17.3

u/l

0.23

286

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

177

1087

1.64

8.88

1.4

1.6

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

178

1096

1.64

8.84

2.6

1.9

4.6

8.8

titre

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

125

698

1.80

8.84

1.9

1.6

—

(3014271) Vancomycin [Susceptibility]

161

2.74

8.83

3.5

2.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

399

2.07

8.72

1.7

2.2

97.4

96.4

0.10

365

(3017569) Oxygen content in Arterial blood

180

2.62

8.65

1.9

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

107

574

1.87

8.61

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

141

2.85

8.61

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

199

1268

1.58

8.60

1.1

2.8

3.4

u/ml

0.34

704

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

128

727

1.77

8.56

1.5

1.4

382.1

294.4

pmol/l

0.76

106

575

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1669

14510

1.19

8.52

1.6

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

130

744

1.76

8.48

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

104

556

1.88

8.47

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

461

1.96

8.33

1.8

2.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

159

971

1.65

8.19

2.6

2.9

912.3

1382.9

u/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

384

2.04

8.07

1.1

1.0

1.1

u/l

0.25

170

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.01

8.05

1.8

1.6

3.0

4.2

mg/l

0.39

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.01

8.05

1.8

1.6

0.5

2.1

mg/l

0.93

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.01

8.05

1.8

1.6

1.8

3.8

mg/l

1.00

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.01

8.05

1.8

1.6

2.1

2.7

mg/l

0.13

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.01

8.05

1.8

1.6

1.2

3.2

mg/l

1.29

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.01

8.05

1.8

1.6

1.8

2.4

mg/l

0.27

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.01

8.05

1.8

1.6

0.7

1.6

mg/l

0.82

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.01

8.05

1.8

1.6

0.7

3.1

mg/l

2.12

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.01

8.05

1.8

1.6

0.9

2.0

mg/l

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

503

1.90

7.99

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

462

1.94

7.94

1.4

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

142

2.75

7.93

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

512

1.88

7.90

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

137

813

1.70

7.89

1.7

1.4

—

(3036603) Volume of Urine

381

2.03

7.87

1.6

1.5

2255.6

1948.3

0.51

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.94

7.86

1.8

1.6

0.3

2.7

mg/l

2.52

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

513

1.88

7.86

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

478

1.91

7.85

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

514

1.88

7.81

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

342

2.08

7.80

1.2

79.1

81.7

u/l

0.09

300

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

117

667

1.76

7.77

1.8

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.33

7.67

1.1

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

433

1.95

7.67

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

359

2.04

7.60

1.7

123.6

134.7

0.88

336

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.97

7.60

1.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

107

599

1.80

7.57

2.9

2.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

108

2.97

7.48

1.1

0.6

0.7

umol/24h

0.93

(40761536) Microorganisms panel - Urine sediment

716

5797

1.26

7.44

4.6

3.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

487

1.88

7.44

1.1

1.0

290.8

290.2

mg/l

0.02

450

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

5.18

7.44

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

459

1.90

7.43

1.3

1.4

nmol/l

0.05

411

(44806118)

116

669

1.74

7.43

1.4

1.5

—

(44790049)

116

669

1.74

7.43

1.4

1.5

—

(44790047)

116

669

1.74

7.43

1.4

1.5

—

(44790048)

116

669

1.74

7.43

1.4

1.5

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

257

2.23

7.41

1.6

1.8

144.9

156.1

0.45

239

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

3.07

7.41

1.6

1.4

0.2

0.3

nmol/l

0.67

(3017732) Neutrophils [#/volume] in Blood

594

4705

1.28

7.41

2.8

2.2

4.0

4.1

e9/l

0.85

472

3888

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

174

1115

1.57

7.40

1.1

121.9

116.5

1.59

157

1017

(3019832) Treponema pallidum Ab [Presence] in Serum

1407

12188

1.18

7.40

1.8

1.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

439

1.92

7.38

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

506

1.85

7.23

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

507

1.84

7.19

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

254

2.21

7.19

1.2

116.5

109.6

0.65

224

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

508

1.84

7.15

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.55

7.13

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

145

2.63

7.10

1.0

—

(3037756) Immunofixation for Serum or Plasma

145

900

1.62

7.07

1.4

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

164

2.51

6.98

1.9

1.7

—

(3033942) Copper [Moles/time] in 24 hour Urine

5.19

6.96

1.3

1.0

2.3

0.2

umol/24h

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

252

2.19

6.91

1.0

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

164

1058

1.56

6.81

2.7

2.9

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

197

1324

1.50

6.78

3.4

3.5

57.7

56.6

0.64

197

1324

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

145

910

1.60

6.78

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

375

4924

0.75

6.75

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

108

630

1.72

6.69

2.1

3.1

4.3

12.6

nmol/l

0.47

103

611

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

163

1056

1.55

6.66

1.1

7.2

1621.7

iu/ml

0.81

255

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

508

1.80

6.56

1.2

1.3

0.5

1.4

u/ml

0.93

200

(3022493) Free Hemoglobin [Mass/volume] in Plasma

245

2.17

6.53

5.6

5.9

99.8

1664.2

mg/l

0.75

173

(3044941) Cell count panel - Synovial fluid

132

820

1.62

6.45

1.7

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

129

798

1.63

6.42

1.1

96.7

94.9

0.35

119

758

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

147

2.52

6.41

1.1

103.7

85.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

101

587

1.73

6.36

1.3

1.4

65.9

62.8

pmol/l

0.08

165

(3000475) Leukocytes [#/volume] in Synovial fluid

185

1245

1.50

6.36

1.8

1.6

11625.4

13305.2

e6/l

0.22

134

906

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

148

2.51

6.33

1.2

1.1

72.7

73.1

—

(4268621)

131

817

1.61

6.31

2.4

2.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

4.22

6.27

1.1

1.0

11.8

15.9

u/l

0.22

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1044

8955

1.19

6.11

1.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

102

602

1.70

6.09

1.4

1.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

247

2.11

6.02

1.3

1.2

0.3

g/l

0.20

199

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

140

2.51

6.00

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

248

2.10

5.96

1.1

96.4

92.1

0.33

121

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

139

893

1.57

5.94

2.0

1.8

—

(40757494) Bilirubin.total [Moles/volume] in Blood

249

2.09

5.90

1.8

2.9

28.5

76.3

umol/l

—

(3000012) Reticulocyte production index

249

2.09

5.90

1.2

1.4

—

(3023419) Bacteria identified in Sputum by Culture

580

1.70

5.82

2.6

2.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

244

2.10

5.81

1.1

1.2

98.6

93.3

0.42

122

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

119

2.61

5.78

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.61

5.75

1.2

1.1

—

(3002256) Pathology report gross observation

990

8512

1.18

5.64

1.2

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

121

2.57

5.61

1.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

268

2.02

5.59

1.4

1.3

238.6

61.3

titre

—

(3023420) DNA double strand Ab [Units/volume] in Serum

120

757

1.59

5.57

1.9

1.6

27.2

34.4

iu/ml

0.39

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

596

1.67

5.54

2.0

1.6

—

(44813793)

522

1.71

5.48

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

204

2.16

5.45

1.7

2.0

190.0

224.5

e6/l

0.36

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

117

2.57

5.44

1.6

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

278

1.98

5.43

35.6

35.3

7.3

7.4

ug/l

0.10

256

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

286

2143

1.35

5.42

2.1

1.8

—

(3011412) CD3 cells [#/volume] in Blood

102

623

1.64

5.41

1.9

2.4

1.4

1.2

e9/l

1.38

356

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

279

1.98

5.38

1.5

1.3

273.3

258.9

titre

—

(4306422)

171

1175

1.46

5.37

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

310

2356

1.33

5.35

2.1

1.9

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

168

1154

1.46

5.29

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

240

2.05

5.28

2.4

2.2

53.7

50.0

umol/l

0.29

206

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

403

1.79

5.23

1.3

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

102

2.65

5.22

1.1

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

130

853

1.53

5.12

2.8

3.5

1.5

1.4

0.15

651

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

190

2.16

5.10

2.1

58.8

63.1

ug/l

0.15

185

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

399

1.79

5.10

1.4

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

363

1.82

5.09

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

466

1.72

5.08

1.7

2.5

656.0

511.3

e6/l

0.58

382

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

13.34

5.07

1.1

1.0

—

mmol/l

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

505

1.69

5.03

1.8

2.1

11.5

14.9

1.94

246

(3014051) Protein [Presence] in Urine by Test strip

201

1442

1.40

5.02

2.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

590

1.63

5.00

1.2

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.81

4.97

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

193

1378

1.41

4.96

1.6

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

374

1.80

4.93

2.3

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

187

2.14

4.89

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

110

705

1.57

4.83

3.4

3.1

0.8

nmol/l

0.19

531

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

114

738

1.55

4.80

1.8

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

149

1027

1.46

4.66

2.5

3.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

107

688

1.56

4.65

2.6

4.9

95.5

92.1

u/ml

0.02

224

(3004616) Nuclear Ab [Presence] in Serum

117

768

1.53

4.64

1.4

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

296

1.86

4.58

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

179

2.13

4.58

2.3

2.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

233

1.98

4.57

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

504

1.65

4.57

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

466

1.68

4.56

3.2

2.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

222

1647

1.36

4.56

2.2

1.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

221

2.00

4.48

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

292

1.85

4.44

1.5

1.8

1.3

nmol/l

0.01

232

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.00

4.39

14.9

11.3

5.2

5.7

mmol/l

0.43

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

111

731

1.53

4.36

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.72

4.36

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

129

877

1.48

4.35

1.1

1.6

1.5

g/l

1.46

114

806

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

199

1464

1.37

4.33

1.3

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

109

717

1.53

4.31

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

452

1.66

4.27

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

616

1.56

4.25

2.1

2.0

20.0

26.5

mg/l

0.46

158

(3032057) Clostridioides difficile [Presence] in Stool

2.56

4.20

1.7

2.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.52

4.04

1.4

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

108

720

1.51

4.04

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

266

1.85

4.02

2.3

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

317

1.77

4.01

1.5

27.4

17.7

u/ml

0.70

(3025468) Yersinia sp identified in Specimen by Organism specific culture

106

708

1.50

3.94

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

502

1.60

3.92

3.0

73.8

60.5

mg/l

0.16

370

(3000330) Specific gravity of Urine by Test strip

355

2867

1.25

3.91

3.5

2.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

106

710

1.50

3.89

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

343

1.72

3.87

1.5

1.6

4.4

5.3

u/l

0.19

174

(3005988) Vibrio sp identified in Specimen by Organism specific culture

106

711

1.50

3.87

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

270

1.82

3.85

1.1

—

(4094501)

213

1616

1.33

3.83

1.1

—

(3021788) Differential panel - Synovial fluid

140

994

1.42

3.81

1.6

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1042

9272

1.14

3.78

2.7

2.8

0.6

0.8

ug/l

3.71

668

5505

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

523

1.57

3.77

1.2

1.3

50.0

230.6

titre

4.65

105

(3001964) Herpes simplex virus Ag [Presence] in Specimen

181

1.99

3.72

1.1

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

223

1.89

3.71

1.2

1.1

—

0.2

g/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

175

2.00

3.67

1.5

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

304

1.75

3.66

2.2

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

312

1.74

3.64

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

129

2.17

3.62

1.3

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.25

3.62

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

427

1.62

3.61

1.9

2.0

0.4

1.8

g/24h

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

461

1.59

3.52

1.7

2.6

0.3

0.2

e9/l

0.30

384

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

165

2.00

3.48

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

272

1.77

3.47

2.4

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

542

1.54

3.47

1.5

1.7

—

(3041354) Potassium [Moles/volume] in Venous blood

559

1.53

3.45

2.8

2.0

4.0

mmol/l

0.06

549

(3035285) Chloride [Moles/volume] in Venous blood

559

1.53

3.45

2.8

2.0

105.8

105.5

mmol/l

0.26

549

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

106

2.27

3.44

1.6

0.3

0.4

ug/l

0.84

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

168

1253

1.35

3.43

1.1

—

(3022475) Manganese [Moles/volume] in Blood

2.98

3.40

1.2

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

237

1859

1.28

3.38

2.9

3.7

225.2

2914.0

u/ml

1.11

209

1611

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

142

1035

1.38

3.36

1.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

7.00

3.36

1.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.25

3.34

1.2

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.32

3.33

1.4

1.8

34.0

40.5

pmol/l

0.25

(3005011) Chlamydia sp Ab [Titer] in Serum

108

2.23

3.31

1.6

1.5

—

(3045424) Erythrocytes [Presence] in Urine

149

1098

1.36

3.31

1.4

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

139

1884

0.73

3.29

1.1

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

610

5282

1.17

3.26

3.1

4.2

6.7

27.1

ug/l

2.21

469

4088

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

142

2.05

3.25

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

780

6890

1.15

3.18

4.3

3.8

31.3

32.6

2.40

571

4905

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.31

3.16

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.73

3.15

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.63

3.13

1.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

549

1.50

3.10

2.8

3.9

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.29

3.09

2.4

2.9

57.1

23.7

mg/l

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.08

2.3

1.6

—

(3007919) Fasciola sp Ab [Titer] in Serum

7.50

3.05

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.68

3.05

1.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

463

1.54

3.04

1.1

7.6

8.6

iu/ml

—

130

(3000093) Morphology [Interpretation] in Blood Narrative

504

1.51

3.01

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1230

0.69

3.00

1.4

1.6

—

(3024263) Appearance of Synovial fluid

278

1.69

2.98

2.3

1.8

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

107

2.15

2.95

1.0

1.1

0.0

u/ml

0.25

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.54

2.95

1.1

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.15

2.92

2.8

1.6

59.2

44.3

umol/l

0.74

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

235

1.75

2.91

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

549

1.48

2.91

2.9

2.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

217

1722

1.27

2.88

1.1

6.0

6.1

u/ml

0.01

128

915

(3013336) Amino acids [Identifier] in Serum or Plasma

5.39

2.86

1.3

2.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.93

2.85

2.3

1.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

116

844

1.38

2.84

2.9

3.1

440.7

730.3

u/ml

0.22

111

776

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.19

2.82

2.0

2.2

6.2

8.2

mmol/l

3.07

(40761539) Cells [Type] in Urine sediment by Light microscopy

137

1.97

2.79

1.4

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.36

2.72

1.0

1.1

—

(3014891) Appearance of Pleural fluid

2.71

2.5

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

105

2.10

2.68

5.7

6.0

—

(3022689) Creatine [Moles/volume] in Urine

175

1.83

2.67

1.7

1.5

—

(3013727) Leukocytes other/100 leukocytes in Blood

168

1.85

2.66

3.2

3.7

55.0

49.3

0.98

159

(3051593) INR in Capillary blood by Coagulation assay

168

1.85

2.66

4.6

11.7

—

(3012565) Volume of 24 hour Urine

291

1.62

2.55

1.9

2.3

1970.1

2064.5

0.23

267

(3044927) Protein electrophoresis panel - Urine

426

1.51

2.55

1.2

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.73

2.54

1.0

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.13

2.54

3.1

2.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

451

1.49

2.53

1.8

2.6

848.2

745.2

e6/l

0.48

196

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.50

2.52

1.1

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

462

0.54

2.52

1.2

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

2.27

2.50

1.0

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

477

1.47

2.50

1.2

—

48.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

669

1.39

2.48

1.2

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

429

1.50

2.48

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

429

1.50

2.48

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

429

1.50

2.48

1.5

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

302

1.59

2.46

1.3

—

(3042733) HLA Ab [Presence] in Serum

204

1.72

2.40

5.8

5.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

557

1.42

2.38

2.3

42.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.25

2.37

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

2.21

2.37

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

1.90

2.35

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

306

1.57

2.34

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

362

1.52

2.34

2.3

2.6

41.6

41.0

0.07

130

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

237

1.65

2.31

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

237

1.65

2.31

1.3

—

(3001556) Androgen free Index in Serum or Plasma

112

1.97

2.29

1.7

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

470

1.45

2.29

1.2

1.3

41.8

32.1

u/ml

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.45

2.27

1.1

1.4

1.6

umol/24h

0.69

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.22

2.27

2.8

1.5

1.6

2.1

mmol/l

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

236

1948

1.22

2.27

1.1

1.3

1.5

u/ml

0.09

782

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

333

1.53

2.26

1.1

11.9

15.1

u/ml

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

113

1.95

2.24

1.2

0.7

62.6

mg/l

0.71

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

216

1.67

2.24

4.4

4.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.34

2.21

1.0

1.1

0.1

2.8

u/ml

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

450

1.45

2.18

1.2

1.3

2.6

13.1

u/ml

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

258

1.59

2.14

1.1

33.7

21.6

u/l

0.33

206

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

596

1.38

2.11

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

430

3765

1.15

2.09

2.7

3.1

37.2

43.1

u/ml

0.46

418

3651

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

260

1.58

2.08

1.1

105.0

84.9

u/l

0.44

214

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.14

2.08

1.1

1.2

23.5

63.7

—

(3028433) Virus identified in Specimen by Culture

198

1.67

2.08

1.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

202

1659

1.22

2.07

1.1

1.0

1.2

u/ml

0.20

722

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.08

2.06

3.1

2.5

—

(4015189)

103

1.94

2.04

2.8

2.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

166

1338

1.25

2.03

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

441

1.43

2.02

1.3

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

270

1.56

2.02

1.0

1.1

19.3

u/ml

0.86

156

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.81

2.00

1.0

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

201

1659

1.22

1.98

1.1

1.2

2.3

u/ml

1.07

429

(3012898) Urea [Moles/volume] in Urine

2.28

1.97

1.7

1.9

191.4

179.1

mmol/l

0.11

(40761995) Spermatozoa Progressive [#/volume] in Semen

311

0.51

1.97

3.1

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

311

0.51

1.97

6.1

6.4

—

(3046861) Legionella sp Ag [Presence] in Urine

3.34

1.96

1.7

1.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

520

1.39

1.95

2.4

3.5

57.9

57.0

0.13

332

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.55

1.94

1.0

1.2

155.7

105.0

nmol/24h

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

142

1.76

1.92

1.7

5905.6

23381.2

e6/l

—

(3028717) Thiamine [Mass/volume] in Blood

2.24

1.90

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

351

4024

0.87

1.89

1.4

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1138

0.75

1.88

1.5

1.6

7.4

7.5

mmol/l

0.18

699

(3020874) Milk IgE Ab [Units/volume] in Serum

618

1.35

1.88

1.1

8.5

2.6

u/ml

0.36

163

(1761482) Bacteria [#/volume] in Urine by Culture

157

1275

1.24

1.83

4.9

3.4

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

4.17

1.82

1.2

1.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

4.17

1.82

1.0

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

376

1.44

1.81

1.8

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

2.06

1.80

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.00

1.79

1.1

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

715

0.70

1.79

2.3

1.7

—

(3012441) Differential panel - Pleural fluid

437

1.40

1.76

1.7

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

151

1228

1.23

1.75

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

669

1.32

1.75

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.90

1.75

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

2.67

1.72

1.3

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

3.85

1.71

1.0

1.2

—

(40768806) Pleura Pathology biopsy report

457

1.38

1.70

1.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

1.70

0.0

2.1

—

(3024932) HLA-DR beta [Type]

218

1.56

1.70

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.03

1.64

1.0

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

565

1.33

1.61

1.6

1.5

32.6

33.3

g/l

0.20

522

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.57

1.61

8.2

9.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

462

1.37

1.61

1.6

1.4

18844.4

56936.5

e6/l

1.18

264

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

166

1.63

1.61

1.1

1.2

0.5

5.2

u/ml

1.36

118

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1030

0.76

1.60

1.4

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

174

1.61

1.60

1.3

1.5

10.4

8.3

ug/l

1.76

174

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

151

1243

1.22

1.59

2.2

2.5

128.6

109.8

ug/min

0.14

809

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.91

1.59

1.1

0.1

0.6

u/ml

—

(3024471) HLA-A [Type]

222

1.53

1.59

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.00

1.58

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

329

3728

0.88

1.55

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

466

1.35

1.54

1.5

1.4

93642.8

84638.0

e6/l

0.05

325

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.97

1.53

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

330

3734

0.88

1.53

1.4

1.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.33

1.52

2.4

1.6

1.9

2.2

mmol/24h

—

(3002619) Bacteria identified in Specimen by Culture

115

1.74

1.52

1.1

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

330

3732

0.88

1.52

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

459

1.35

1.51

2.5

2.2

—

(3020491) Glucose [Moles/volume] in Blood

511

1.33

1.51

1.8

6.5

6.1

mmol/l

0.44

377

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.86

1.50

1.0

1.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.86

1.50

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.86

1.50

9.8

8.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

266

1.47

1.50

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.86

1.50

1.1

1.4

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

120

1472

0.81

1.48

3.4

2.1

13.0

13.1

0.62

120

1456

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

178

1.57

1.48

2.3

1.9

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.22

1.46

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

514

1.33

1.46

1.6

1.5

6132.8

2293.1

e6/l

0.49

371

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.37

1.45

1.3

1.4

355.1

320.4

umol/24h

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

102

1.77

1.44

1.6

111.7

129.2

ng/l

0.31

102

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.88

1.44

1.2

55.9

96.2

ng/l

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.12

1.44

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

429

1.35

1.44

1.2

1.4

6.0

6.3

mmol/l

0.41

402

(3023430) Cat dander IgE Ab [Units/volume] in Serum

158

1323

1.20

1.43

1.1

4.3

4.7

u/ml

0.17

550

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

106

852

1.25

1.42

1.3

1.2

23.2

38.0

u/l

1.36

745

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

110

1.73

1.42

1.3

1.1

18.8

20.1

mmol/l

0.71

101

(3033799) Differential panel - Peritoneal fluid

133

1.66

1.42

1.8

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

330

3710

0.89

1.40

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

157

1.59

1.40

1.7

1.9

273.3

1107.8

e6/l

2.36

105

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

792

1.25

1.39

1.2

1.4

13.3

11.3

mmol/l

1.14

116

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.89

1.38

1.5

1.6

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.08

1.38

1.0

42.5

18.2

u/ml

0.35

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.94

1.38

2.5

2.8

—

(3018001) Oat IgE Ab [Units/volume] in Serum

2.00

1.37

1.1

0.4

0.2

u/ml

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.80

1.37

1.0

0.7

0.1

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

266

2333

1.14

1.36

1.5

1.6

6.3

8.5

iu/ml

0.09

478

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.33

0.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.97

1.32

1.1

—

(3020650) Glucose [Presence] in Urine

232

0.56

1.29

1.2

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.84

1.29

1.4

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.78

1.28

1.0

—

125.3

—

(3035880) pH of Pleural fluid

226

1.46

1.28

1.1

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

167

1423

1.18

1.27

1.1

2.7

4.1

u/ml

0.52

572

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.72

1.26

1.1

0.3

4.1

u/ml

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.22

1.24

1.3

1.0

—

16.6

—

(3034426) Prothrombin time (PT)

271

1.40

1.21

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

104

853

1.22

1.21

1.5

1.7

—

(3044007) Cell count panel - Peritoneal fluid

133

1.58

1.17

1.9

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

472

1.29

1.16

1.4

2.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

111

921

1.21

1.16

1.2

1.3

—

(40768446) Kidney Pathology biopsy report

257

1.40

1.15

2.4

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

250

1.40

1.12

1.8

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

250

1.40

1.12

1.8

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

167

1.50

1.12

1.1

—

2.4

—

(3003694) ABO and Rh group [Type] in Blood

2361

22847

1.05

1.10

1.5

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

371

1.32

1.10

1.0

1.1

101.4

91.3

2.00

304

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

494

1.28

1.10

1.2

1.1

ratio

0.28

175

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.26

1.10

1.0

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

176

1528

1.15

1.10

1.9

2.3

6.3

6.0

umol/l

0.11

140

1135

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.67

1.10

1.1

1.3

36.1

27.0

g/l

—

(3035933) Granulocytes/100 leukocytes in Blood

235

1.41

1.08

4.5

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.87

1.07

1.1

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.12

1.05

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

418

1.29

1.05

1.1

1747.8

1458.4

miu/ml

1.04

418

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

392

1.30

1.04

1.2

3.1

8.3

u/ml

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.27

1.03

1.0

—

(3017704) Immunofixation for Urine

246

1.38

1.03

1.1

1.7

—

(3045788) Cell count panel - Pleural fluid

422

1.28

0.99

1.6

1.5

—

(3004451) EKG impression Narrative

214

1.40

0.99

1.5

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

232

1.38

0.97

3.5

3.7

—

(44806420)

116

1.55

0.96

2.4

2.3

—

(40768441) Liver Pathology biopsy report

435

1.27

0.93

1.3

1.4

—

(4146454)

481

1.25

0.91

2.1

2.7

—

(3013762) Body weight Measured

2.14

0.91

1.2

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

116

993

1.17

0.91

2.5

2.6

—

(3022670) pH of Venous cord blood

2.07

0.89

1.0

1.1

—

(4024509)

537

1.23

0.89

1.6

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

102

0.49

0.89

26.0

4.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.00

0.87

1.0

1.1

—

(3025315) Body weight

1.82

0.85

3.4

3.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.82

0.85

1.1

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

128

1.49

0.85

1.1

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.56

0.84

1.1

0.0

0.3

u/ml

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

320

0.72

0.83

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

139

0.58

0.83

1.0

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

133

1162

1.15

0.82

1.1

0.1

0.4

u/ml

0.87

247

(3000919) Neutrophils/100 leukocytes in Pleural fluid

113

1.51

0.82

1.3

1.5

33.4

19.7

0.98

102

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

113

1.51

0.82

2.9

3.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

285

1.30

0.79

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.67

0.78

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

629

1.19

0.78

1.0

1.1

3.3

2.0

u/ml

0.22

151

(40768800) Prostate Pathology biopsy report

911

0.84

0.77

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

115

1.48

0.76

1.3

1.2

1220.2

271.7

pmol/l

0.47

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.77

0.76

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

458

1.22

0.75

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.08

0.74

9.4

4.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

158

1.39

0.74

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

271

1.29

0.74

1.1

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

560

1.20

0.73

1.6

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.64

0.73

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

172

0.64

0.73

1.3

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

108

1.48

0.73

1.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.00

0.72

1.0

1.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

100

1.50

0.72

1.1

1.0

3.0

u/ml

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.80

0.72

1.9

2.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.67

0.72

2.8

1.2

1.0

mg/l

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.55

0.71

1.0

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

195

1769

1.10

0.69

1.3

4.1

3.6

ug/l

0.34

177

1644

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.53

0.68

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

353

0.76

0.68

1.9

2.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

428

1.22

0.68

1.7

1.9

1.8

2.0

u/field

0.09

188

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

492

1.20

0.67

1.6

1.5

29.1

35.2

0.64

298

(3005082) Progesterone [Moles/volume] in Serum or Plasma

715

1.16

0.66

1.3

1.4

29.1

33.0

nmol/l

0.45

661

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

192

1745

1.10

0.66

1.4

82.9

121.2

pmol/l

1.44

184

1701

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.79

0.66

1.0

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.51

0.66

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

320

2980

1.08

0.64

1.5

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.47

0.64

1.2

1.5

—

(40758292) HTLV I+II Ab panel - Serum

127

0.63

1.0

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

129

0.62

0.63

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

216

1.30

0.63

1.1

50.4

58.0

u/ml

0.22

210

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

252

1.27

0.62

2.3

2.1

18.5

108.7

ug/min

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

270

1.26

0.62

1.3

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

270

1.26

0.62

1.3

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

270

1.26

0.62

1.3

1.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

315

1.24

0.62

1.7

1.5

3.2

3.4

u/field

0.06

224

(4133840)

211

0.71

0.62

1.3

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

105

0.57

0.61

1.2

1.0

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.67

0.61

1.0

1.1

0.0

mg/l

—

(3045142) Bone marrow Pathology biopsy report

621

1.16

0.59

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

575

1.17

0.58

1.0

1.1

0.2

1.6

u/ml

0.81

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

132

1.36

0.57

1.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.62

0.55

1.2

1.1

8.3

8.1

mmol/l

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

125

1.36

0.53

1.3

1.5

1.6

2.5

0.53

106

(44806071)

108

1.39

0.53

1.3

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

666

1.14

0.52

1.7

1.6

53.8

54.2

0.03

422

(40768795) Lymph node Pathology biopsy report

639

0.86

0.50

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

101

1.39

0.49

1.1

1.4

u/ml

—

(4212803)

1.56

0.48

1.1

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

271

1.22

0.48

1.3

1.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

286

3037

0.94

0.47

1.4

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

1.47

0.47

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

115

1043

1.10

0.47

2.3

3.7

85.4

371.1

u/ml

2.40

100

963

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

867

0.89

0.46

1.2

1.1

—

2.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

152

1398

1.09

0.46

4.0

3.1

20.7

26.1

mg/l

1.55

866

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

210

1.24

0.44

1.4

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

210

1.24

0.44

1.4

2.1

—

(3009871) Measles virus Ab [Titer] in Serum

286

0.80

0.44

1.6

1.7

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.35

0.41

1.6

1.4

22.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

213

1.22

0.40

1.4

2.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.33

0.40

1.1

1.0

—

4.2

—

(40768793) Breast Pathology biopsy report

162

1507

1.08

0.40

1.4

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.36

0.40

5.4

5.2

41.3

41.0

ug/min

—

(3019174) dRVVT (LA screen)

1.41

0.39

1.3

1.2

—

(3005033) Fetal Nuchal fold Thickness US

281

2961

0.95

0.39

1.4

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

282

2971

0.95

0.39

1.4

1.5

—

(4211845)

345

1.16

0.37

3.1

2.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.35

0.37

2.6

2.9

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.30

0.37

1.2

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

158

0.76

0.37

1.8

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

358

3430

1.05

0.35

2.1

1.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

192

1.20

0.32

1.1

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

174

1.21

0.31

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.30

0.30

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.27

0.30

3.1

2.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.29

0.30

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

449

1.11

0.29

1.4

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

103

1.26

0.28

1.3

291.7

217.5

ug/l

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

308

1.14

0.27

8.9

5.9

33.8

12072.1

u/ml

0.55

(3006462) Nitrate [Presence] in Urine

318

1.13

0.27

2.9

2.7

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.25

0.25

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

477

0.90

0.25

1.2

—

(4035726)

534

5205

1.03

0.24

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

152

1.18

0.23

1.3

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

115

1.22

0.23

1.5

2.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

147

0.82

0.23

1.1

1.7

1.3

2.0

ug/l

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

144

1.18

0.22

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

144

1.18

0.22

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

144

1.18

0.22

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

144

1.18

0.22

1.1

—

(40757373) Influenza virus identified in Isolate

107

1.22

0.21

1.5

—

(44786800) Granulocytes/100 leukocytes in Body fluid

1.19

0.21

1.2

1.3

35.2

19.9

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.16

0.21

1.0

1.1

—

4.5

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

0.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.20

0.0

1.1

—

59.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

1.0

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.20

0.0

1.1

—

0.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.25

0.20

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

109

1034

1.05

0.20

3.1

3.8

18.5

27.0

u/ml

1.99

101

1006

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

313

0.89

0.20

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

537

5258

1.02

0.19

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

251

1.12

0.18

2.4

2.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.21

0.18

1.1

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

166

1.14

0.18

1.7

2.3

105.3

137.3

ng/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.21

0.17

1.3

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.13

0.17

1.9

—

(4038314)

0.71

0.16

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.20

0.16

1.2

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.75

0.15

2.5

3.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

379

0.92

0.15

2.8

3.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.10

0.15

7.4

6.1

40.4

162.2

g/mol

—

(3051101) Glucose [Moles/volume] in Cord blood

0.79

0.14

5.1

6.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.81

0.13

1.0

12.4

8.9

mu/l

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

480

1.06

0.13

1.7

1.8

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

100

0.80

0.13

2.9

2.8

3531.1

3655.2

u/l

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

288

1.08

0.11

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

1.16

0.11

1.0

7.9

7.3

kpa

0.26

(3006598) pH of Arterial cord blood

1.16

0.11

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

167

0.90

0.10

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

167

0.90

0.10

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

167

0.90

0.10

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

173

1.10

0.10

1.1

—

181.5

—

(3047189) Immunofixation for 24 hour Urine

222

1.08

0.10

1.2

1.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.14

0.10

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.06

0.09

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

162

1583

1.02

0.09

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

370

0.95

0.09

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

439

1.05

0.08

1.7

1.8

4.6

3.9

mg/l

0.35

423

(3038071) Oxygen [Partial pressure] in Mixed venous blood

134

0.90

0.08

15.4

6.9

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

144

0.90

0.08

14.5

6.9

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

146

1.10

0.08

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.14

0.08

1.3

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

161

1578

1.02

0.08

1.1

—

(3016750) Collection duration of Urine

293

1.06

0.08

2.3

2.2

528.1

493.7

min

1.09

230

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

362

1.05

0.07

3.8

3.3

9.0

8.1

mg/l

0.17

289

(3010375) cycloSPORINE [Mass/volume] in Blood

306

0.95

0.07

21.1

26.8

117.0

119.5

ug/l

0.05

261

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

204

0.93

0.07

2.3

3.2

—

(4281824)

681

0.97

0.07

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

442

1.04

0.07

4.9

6.7

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

102

0.88

0.06

6.1

7.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

447

0.96

0.06

1.2

1.3

—

(3004775) Volume in Urine collected for unspecified duration

404

1.04

0.06

2.2

2.3

660.5

640.2

0.11

284

(3034891) Synovial lining cells/100 cells in Synovial fluid

266

1.05

0.06

1.4

4.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

304

0.95

0.05

2.1

2.2

9.3

9.9

mg/l

0.30

256

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

188

1.06

0.05

2.1

1.8

—

612.8

iu/ml

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

110

0.91

0.05

1.9

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

404

0.97

0.05

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

278

1.04

0.04

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

1.09

0.03

1.0

3.3

3.1

kpa

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

108

0.93

0.03

1.1

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

304

3055

0.99

0.02

1.4

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

277

0.97

0.01

1.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

483

1.01

0.01

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1076

10751

1.00

0.00

1.4

—

(3048879) Bone marrow aspiration report

135

0.96

0.00

1.2

2.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

101

0.99

0.00

1.4

2.9

23.6

22.6

mg/l

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

134

0.97

0.00

3.2

2.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

332

0.99

0.00

3.0

2.8

84.1

106.4

au/ml

—

(21494434) Karyotype in Bone marrow

467

1.01

0.00

1.1

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

291

1.00

0.00

1.0

1.1

10.6

7.8

u/ml

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

561

1.00

0.00

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

623

1.00

0.00

1.3

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

126

1265

1.00

0.00

1.3

1.4

7.3

6.8

mmol/l

0.83

920

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

130

1.00

0.00

1.0

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.00

0.00

4.1

2.5

70.9

66.2

pmol/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.91

0.00

1.3

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.02

0.00

1.2

1.3

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

105.3

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.7

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.91

0.00

1.4

2.9

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.4

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.0

—

10.7

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.93

0.00

2.6

1.8

0.4

0.9

u/field

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1922.5

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

5554.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint KRA_PSY_SLEEP_NONORG_EXMORE and mortality.

Females

Parameter	HR [95% CI]	p-value
KRA_PSY_SLEEP_NONORG_EXMORE	1.704 [1.46, 1.99]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.131

During the follow-up period (1.1.1998 — 31.12.2019), 1880 out of 22518 females with KRA_PSY_SLEEP_NONORG_EXMORE died.

Males

Parameter	HR [95% CI]	p-value
KRA_PSY_SLEEP_NONORG_EXMORE	2.505 [2.15, 2.92]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2592 out of 20948 males with KRA_PSY_SLEEP_NONORG_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have KRA_PSY_SLEEP_NONORG_EXMORE.

N-year risk	Females	Males
1	0.11%	0.406%
5	0.878%	2.418%
10	2.091%	6.362%
15	3.916%	11.786%
20	7.157%	19.29%

Relationships between endpoints

↥

Index endpoint: KRA_PSY_SLEEP_NONORG_EXMORE – Nonorganic sleeping disorders, excluding more controls

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Nonorganic sleeping disorders, excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints